Word

CANCERLINQ DISCOVERY

Status

Registered

Status Code

700

Status Date

Tuesday, January 9, 2018

Serial Number

87290547

Registration Number

5376694

Registration Date

Tuesday, January 9, 2018

Mark Type

4000

Filing Date

Thursday, January 5, 2017

Published for Opposition

Tuesday, March 21, 2017

Trademark Owner History

CANCERLINQ LLC -
American Society of Clinical Oncology, Inc. - Original Registrant

Classifications

44 Providing physicians and other healthcare providers information in the field of neoplastic disease prevention, screening, diagnosis and treatment; providing patient information in the field of neoplastic diseases

42 Providing medical and scientific research information in the field of neoplastic diseases to medical and scientific researchers; providing medical and scientific research information in the field of clinical trials for neoplastic diseases; application service provider featuring software for use in providing on-line medical databases; application service provider featuring software for use in aggregating and analyzing health care and medical data; Scientific and medical research, namely, collecting, comparing, and analyzing of patient-level medical and clinical healthcare data and preparing reports in connection therewith

CANCER LINK DISCOVERY

Trademark Events

Jan 31, 2024

Automatic Update Of Assignment Of Ownership

Nov 9, 2023

Teas Section 8 & 15 Received

Jan 9, 2023

Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed

Jan 9, 2018

Registered-Principal Register

Dec 6, 2017

Notice Of Acceptance Of Statement Of Use E-Mailed

Dec 5, 2017

Allowed Principal Register - Sou Accepted

Dec 2, 2017

Statement Of Use Processing Complete

Nov 16, 2017

Use Amendment Filed

Dec 1, 2017

Case Assigned To Intent To Use Paralegal

Nov 16, 2017

Teas Statement Of Use Received

May 16, 2017

Noa E-Mailed - Sou Required From Applicant

Mar 21, 2017

Official Gazette Publication Confirmation E-Mailed

Mar 21, 2017

Published For Opposition

Mar 1, 2017

Notification Of Notice Of Publication E-Mailed

Feb 9, 2017

Approved For Pub - Principal Register

Feb 8, 2017

Examiner's Amendment Entered

Feb 8, 2017

Notification Of Examiners Amendment E-Mailed

Feb 8, 2017

Examiners Amendment E-Mailed

Feb 8, 2017

Examiners Amendment -Written

Jan 31, 2017

Assigned To Examiner

Jan 14, 2017

Notice Of Pseudo Mark E-Mailed

Jan 13, 2017

New Application Office Supplied Data Entered

Jan 9, 2017

New Application Entered